Skip to main content
SpringerLink
Log in

Integration of Energy Metabolism and Control of Apoptosis in Tumor Cells

  • Chapter
  • First Online:
Mitochondria and Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Assaily, W. and Benchimol, S. 2006.Differential utilization of two ATP-generating pathways is regulated by p53. Cancer Cell, 10(1): 4–6.

    Article  CAS  PubMed  Google Scholar 

  • Bernardi, R., et al. 2006.PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature, 442(7104): 779–85.

    Article  CAS  PubMed  Google Scholar 

  • Bhaskar, P.T. and Hay, N. 2007.The two TORCs and Akt. Dev Cell, 12(4): 487–502.

    Article  CAS  PubMed  Google Scholar 

  • Bijur, G.N. and Jope, R.S. 2003.Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport, 14(18): 2415–9.

    Article  CAS  PubMed  Google Scholar 

  • Bonnet, S., et al. 2007.A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell, 11(1): 37–51.

    Article  CAS  PubMed  Google Scholar 

  • Boren, J., et al. 2001.Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem, 276(41): 37747–53.

    CAS  PubMed  Google Scholar 

  • Brdiczka, D., et al. 1998.The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition. Biofactors, 8(3–4): 235–42.

    Article  CAS  PubMed  Google Scholar 

  • Burgering, B.M. and Kops, G.J. 2002.Cell cycle and death control: long live Forkheads. Trends Biochem Sci, 27(7): 352–60.

    Article  CAS  PubMed  Google Scholar 

  • Buzzai, M., et al. 2007.Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res, 67(14): 6745–52.

    Article  CAS  PubMed  Google Scholar 

  • Calissano, P., et al. 1985.Synthesis and content of a DNA-binding protein with lactic dehydrogenase activity are reduced by nerve growth factor in the neoplastic cell line PC12. Exp Cell Res, 161(1): 117–29.

    Article  CAS  PubMed  Google Scholar 

  • Cantley, L.C. and Neel, B.G. 1999.New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA, 96(8): 4240–5.

    Article  CAS  PubMed  Google Scholar 

  • Carling, D., 2004.The AMP-activated protein kinase cascade—A unifying system for energy control. Trends Biochem Sci, 29(1): 18–24.

    Article  CAS  PubMed  Google Scholar 

  • Casey, J.R., 2006.Why bicarbonate? Biochem Cell Biol, 84(6): 930–9.

    Article  CAS  PubMed  Google Scholar 

  • Cattaneo, A., et al. 1985.Nuclear localization of a lactic dehydrogenase with single-stranded DNA-binding properties. Exp Cell Res, 161(1): 130–40.

    Article  CAS  PubMed  Google Scholar 

  • Chesney, J., 2006.6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care, 9(5): 535–9.

    Article  CAS  PubMed  Google Scholar 

  • Choo, A.Y. and Blenis, J. 2006.TORgeting oncogene addiction for cancer therapy. Cancer Cell, 9(2): 77–9.

    Article  CAS  PubMed  Google Scholar 

  • Discher, D.J., et al. 1998.Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J Biol Chem, 273(40): 26087–93.

    Article  CAS  PubMed  Google Scholar 

  • Dombrauckas, J.D., Santarsiero, and B.D. Mesecar, A.D. 2005.Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry, 44(27): 9417–29.

    Article  CAS  PubMed  Google Scholar 

  • Edinger, A.L. and Thompson, C.B. 2002.Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell, 13(7): 2276–88.

    Article  CAS  PubMed  Google Scholar 

  • Fang, J., et al. 2006.The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol, 70(6): 2108–15.

    Article  CAS  PubMed  Google Scholar 

  • Fantin, V.R., St-Pierre, and J. Leder, P. 2006.Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell, 9(6): 425–34.

    Article  CAS  PubMed  Google Scholar 

  • Fell, D., 1997:Understanding the Control of Metabolism. Portland Press, London.

    Google Scholar 

  • Fell, D.A., 1998.Increasing the flux in metabolic pathways: A metabolic control analysis perspective. Biotechnol Bioeng, 58(2–3): 121–4.

    Article  CAS  PubMed  Google Scholar 

  • Fischer, K., et al. 2007.Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood, 109(9): 3812–9.

    Article  CAS  PubMed  Google Scholar 

  • Forde, J.E. and Dale, T.C. 2007.Glycogen synthase kinase 3: A key regulator of cellular fate. Cell Mol Life Sci, 64(15): 1930–44.

    Article  CAS  PubMed  Google Scholar 

  • Frey, T.G. and Mannella, C.A. 2000.The internal structure of mitochondria. Trends Biochem Sci, 25(7): 319–24.

    Article  CAS  PubMed  Google Scholar 

  • Gatenby, R.A. and Gillies, R.J. 2004.Why do cancers have high aerobic glycolysis? Nat Rev Cancer, 4(11): 891–9.

    Article  CAS  PubMed  Google Scholar 

  • Granville, D.J. and Gottlieb, R.A. 2003.The mitochondrial voltage-dependent anion channel (VDAC) as a therapeutic target for initiating cell death. Curr Med Chem, 10(16): 1527–33.

    Article  CAS  PubMed  Google Scholar 

  • Hardie, D.G., 2004.The AMP-activated protein kinase pathway—New players upstream and downstream. J Cell Sci, 117(Pt 23): 5479–87.

    Article  CAS  PubMed  Google Scholar 

  • Hardie, D.G., 2005.New roles for the LKB1→AMPK pathway. Curr Opin Cell Biol, 17(2): 167–73.

    Article  CAS  PubMed  Google Scholar 

  • Hardt, P.D., et al. 2004.Faecal tumour M2 pyruvate kinase: A new, sensitive screening tool for colorectal cancer. Br J Cancer, 91(5): 980–4.

    CAS  PubMed  Google Scholar 

  • Hay, N., 2005.The Akt-mTOR tango and its relevance to cancer. Cancer Cell, 8(3): 179–83.

    Article  CAS  PubMed  Google Scholar 

  • Imai, K., et al. 2006.LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cells. Biochem Biophys Res Commun, 351(3): 595–601.

    Article  CAS  PubMed  Google Scholar 

  • Inoki, K., et al. 2002.TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol, 4(9): 648–57.

    Article  CAS  PubMed  Google Scholar 

  • Inoki, K., Zhu, and T. Guan, K.L. 2003.TSC2 mediates cellular energy response to control cell growth and survival. Cell, 115(5): 577–90.

    Article  CAS  PubMed  Google Scholar 

  • Inoki, K., et al. 2006.TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell, 126(5): 955–68.

    Article  CAS  PubMed  Google Scholar 

  • Jones, R.G., et al. 2005.AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell, 18(3): 283–93.

    Article  CAS  PubMed  Google Scholar 

  • Kacser, H. and Burns, J.A. 1973.The control of flux. Symp Soc Exp Biol, 27: 65–104.

    CAS  PubMed  Google Scholar 

  • Kato, K., et al. 2002.Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene, 21(39): 6082–90.

    Article  CAS  PubMed  Google Scholar 

  • Kim, A.H., et al. 2001.Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol, 21(3): 893–901.

    Article  CAS  PubMed  Google Scholar 

  • Kim, J.W. and Dang, C.V. 2005.Multifaceted roles of glycolytic enzymes. Trends Biochem Sci, 30(3): 142–50.

    Article  CAS  PubMed  Google Scholar 

  • Kim, J.W. and Dang, C.V. 2006.Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res, 66(18): 8927–30.

    Article  CAS  PubMed  Google Scholar 

  • Kim, J.W., et al. 2006.HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab, 3(3): 177–85.

    Article  PubMed  Google Scholar 

  • King, A., Selak, and M.A. Gottlieb, E. 2006.Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene, 25(34): 4675–82.

    Article  CAS  PubMed  Google Scholar 

  • Kruse, J.P. and Gu, W. 2006.p53 aerobics: The major tumor suppressor fuels your workout. Cell Metab, 4(1): 1–3.

    Article  CAS  PubMed  Google Scholar 

  • Kumar, Y., et al. 2007.Tumour M2-pyruvate kinase: A gastrointestinal cancer marker. Eur J Gastroenterol Hepatol, 19(3): 265–76.

    Article  CAS  PubMed  Google Scholar 

  • Li, Y., et al. 2004.TSC2: Filling the GAP in the mTOR signaling pathway. Trends Biochem Sci, 29(1): 32–8.

    Article  PubMed  Google Scholar 

  • Luo, Z., et al. 2005.AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci, 26(2): 69–76.

    Article  CAS  PubMed  Google Scholar 

  • Ma, W., et al.,A pivotal role for p53: Balancing aerobic respiration and glycolysis. J Bioenerg Biomembr, 2007.

    Google Scholar 

  • MacKenzie, E.D., et al. 2007.Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol, 27(9): 3282–9.

    Article  CAS  PubMed  Google Scholar 

  • Majewski, N., et al. 2004.Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell, 16(5): 819–30.

    Article  CAS  PubMed  Google Scholar 

  • Manning, B.D. and Cantley, L.C. 2007.AKT/PKB signaling: Navigating downstream. Cell, 129(7): 1261–74.

    Article  CAS  PubMed  Google Scholar 

  • Marchetti, P., et al. 1996.Mitochondrial permeability transition is a central coordinating event of apoptosis. Journal of Experimental Medicine, 184(3): 1155–60.

    Article  CAS  PubMed  Google Scholar 

  • Marshall, S., 2006.Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: A nutritional perspective of diabetes, obesity, and cancer. Sci STKE, 2006(346): re7.

    Article  PubMed  Google Scholar 

  • Mathupala, S.P., Heese, and C. Pedersen, P.L. 1997.Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem, 272(36): 22776–80.

    Article  CAS  PubMed  Google Scholar 

  • Mathupala, S.P., Ko, and Y.H. Pedersen, P.L. 2006.Hexokinase II: Cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene, 25(34): 4777–86.

    Article  CAS  PubMed  Google Scholar 

  • Matoba, S., et al. 2006.p53 regulates mitochondrial respiration. Science, 312(5780): 1650–3.

    Article  CAS  PubMed  Google Scholar 

  • Mazurek, S., Boschek, and C.B. Eigenbrodt, E. 1997.The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr, 29(4): 315–30.

    Article  CAS  PubMed  Google Scholar 

  • Mazurek, S., et al. 2002.Pyruvate kinase type M2: A crossroad in the tumor metabolome. Br J Nutr, 87(Suppl 1): S23–9.

    Article  CAS  PubMed  Google Scholar 

  • Mazurek, S., et al. 2005.Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol, 15(4): 300–8.

    Article  CAS  PubMed  Google Scholar 

  • Minchenko, A., et al. 2002.Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem, 277(8): 6183–7.

    Article  CAS  PubMed  Google Scholar 

  • Modur, V., et al. 2002.FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem, 277(49): 47928–37.

    Article  CAS  PubMed  Google Scholar 

  • Moll, U.M., Marchenko, and N. Zhang, X.K. 2006.p53 and Nur77/TR3—Transcription factors that directly target mitochondria for cell death induction. Oncogene, 25(34): 4725–43.

    Article  CAS  PubMed  Google Scholar 

  • Moreno-Sanchez, R., et al. 2007.Energy metabolism in tumor cells. Febs J, 274(6): 1393–418.

    Article  CAS  PubMed  Google Scholar 

  • Papandreou, I., et al. 2006.HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab, 3(3): 187–97.

    Article  CAS  PubMed  Google Scholar 

  • Pastorino, J.G. and Hoek, J.B. 2003.Hexokinase II: The integration of energy metabolism and control of apoptosis. Curr Med Chem, 10(16): 1535–51.

    Article  CAS  PubMed  Google Scholar 

  • Pastorino, J.G., Shulga, and N. Hoek, J.B. 2002.Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem, 277(9): 7610–8.

    Article  CAS  PubMed  Google Scholar 

  • Pastorino, J.G., Hoek, and J.B. Shulga, N. 2005.Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res, 65(22): 10545–54.

    Article  CAS  PubMed  Google Scholar 

  • Pedersen, P.L., et al. 2002.Mitochondrial bound type II hexokinase: A key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta, 1555(1–3): 14–20.

    CAS  PubMed  Google Scholar 

  • Pelicano, H., et al. 2006.Glycolysis inhibition for anticancer treatment. Oncogene, 25(34): 4633–46.

    Article  CAS  PubMed  Google Scholar 

  • Plas, D.R. and Thompson, C.B. 2005.Akt-dependent transformation: There is more to growth than just surviving. Oncogene, 24(50): 7435–42.

    Article  CAS  PubMed  Google Scholar 

  • Provent, P., et al. 2007.Serial in vivo spectroscopic nuclear magnetic resonance imaging of lactate and extracellular pH in rat gliomas shows redistribution of protons away from sites of glycolysis. Cancer Res, 67(16): 7638–45.

    Article  CAS  PubMed  Google Scholar 

  • Reiling, J.H. and Hafen, E. 2004.The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev, 18(23): 2879–92.

    Article  CAS  PubMed  Google Scholar 

  • Roe, J.S., et al. 2006.p53 stabilization and transactivation by a von Hippel-Lindau protein. Mol Cell, 22(3): 395–405.

    Article  CAS  PubMed  Google Scholar 

  • Rutter, G.A., Da Silva Xavier, and G. Leclerc, I. 2003.Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J, 375(Pt 1): 1–16.

    Article  CAS  PubMed  Google Scholar 

  • Schwarzer, R., et al. 2005.REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene, 24(7): 1138–49.

    Article  CAS  PubMed  Google Scholar 

  • Semenza, G.L.,HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr, 2007.

    Google Scholar 

  • Shaw, R.J., 2006.Glucose metabolism and cancer. Curr Opin Cell Biol, 18(6): 598–608.

    Article  CAS  PubMed  Google Scholar 

  • Shim, H., et al. 1997.c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc Natl Acad Sci USA, 94(13): 6658–63.

    Article  CAS  PubMed  Google Scholar 

  • Shimizu, S., Narita, and M. Tsujimoto, Y. 1999.Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399(6735): 483–7.

    Article  CAS  PubMed  Google Scholar 

  • Stetak, A., et al. 2007.Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res, 67(4): 1602–8.

    Article  CAS  PubMed  Google Scholar 

  • Sui, D. and Wilson, J.E. 1997.Structural determinants for the intracellular localization of the isozymes of mammalian hexokinase: Intracellular localization of fusion constructs incorporating structural elements from the hexokinase isozymes and the green fluorescent protein. Arch Biochem Biophys, 345(1): 111–25.

    Article  CAS  PubMed  Google Scholar 

  • Sun, X., et al. 2006.Overexpression of von Hippel–Lindau tumor suppressor protein and antisense HIF-1alpha eradicates gliomas. Cancer Gene Ther, 13(4): 428–35.

    Article  CAS  PubMed  Google Scholar 

  • Sunters, A., et al. 2003.FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem, 278(50): 49795–805.

    Article  CAS  PubMed  Google Scholar 

  • Swinnen, J.V., Brusselmans, and K. Verhoeven, G. 2006.Increased lipogenesis in cancer cells: New players, novel targets. Curr Opin Clin Nutr Metab Care, 9(4): 358–65.

    Article  CAS  PubMed  Google Scholar 

  • Tomita, K., et al. 2005.AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol Clin Exp Res, 29(12 Suppl): 240S–5S.

    CAS  PubMed  Google Scholar 

  • Vander Heiden, M.G., et al. 2001.Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol, 21(17): 5899–912.

    Article  CAS  PubMed  Google Scholar 

  • Vyssokikh, M.Y., et al. 2002.Bax releases cytochrome c preferentially from a complex between porin and adenine nucleotide translocator. Hexokinase activity suppresses this effect. Mol Biol Rep, 29(1–2): 93–6.

    Article  CAS  PubMed  Google Scholar 

  • Warburg, O., 1930:Metabolism of Tumors. Arnold Constable, London.

    Google Scholar 

  • Watcharasit, P., et al. 2003.Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J Biol Chem, 278(49): 48872–9.

    Article  CAS  PubMed  Google Scholar 

  • Weinhouse, S., 1972.Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. Cancer Res, 32(10): 2007–16.

    CAS  PubMed  Google Scholar 

  • Williams, K.R., Reddigari, and S. Patel, G.L. 1985.Identification of a nucleic acid helix-destabilizing protein from rat liver as lactate dehydrogenase-5. Proc Natl Acad Sci USA, 82(16): 5260–4.

    Article  CAS  PubMed  Google Scholar 

  • Wilson, J.E., 2003.Isozymes of mammalian hexokinase: Structure, subcellular localization and metabolic function. J Exp Biol, 206(Pt 12): 2049–57.

    Article  CAS  PubMed  Google Scholar 

  • Wilson, J.E., 1995.Hexokinases. Rev Physiol Biochem Pharmacol, 126: 65–198.

    Article  CAS  PubMed  Google Scholar 

  • Woods, A., et al. 2003.LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol, 13(22): 2004–8.

    Article  CAS  PubMed  Google Scholar 

  • Wu, M., et al. 2007.Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol, 292(1): C125–C36.

    Article  CAS  PubMed  Google Scholar 

  • Xie, G.C. and Wilson, J.E. 1988.Rat brain hexokinase: The hydrophobic N-terminus of the mitochondrially bound enzyme is inserted in the lipid bilayer. Arch Biochem Biophys, 267(2): 803–10.

    Article  CAS  PubMed  Google Scholar 

  • Yu, J., et al. 2001.PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell, 7(3): 673–82.

    Article  CAS  PubMed  Google Scholar 

  • Zhang, H., et al. 2007.HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell, 11(5): 407–20.

    Article  CAS  PubMed  Google Scholar 

  • Zhu, W., et al. 2004.Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells. Brain Res Mol Brain Res, 126(1): 45–56.

    Article  CAS  PubMed  Google Scholar 

  • Zuurbier, C.J., Eerbeek, and O. Meijer, A.J. 2005.Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution. Am J Physiol Heart Circ Physiol, 289(1): H496–H9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. J.G. Pastorino Department of Molecular Biology,, University of Medicine and Dentistry of New Jersey, Stratford, NJ, 08084, USA

    John G. Pastorino

Authors
  1. John G. Pastorino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan B. Hoek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John G. Pastorino .

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Pastorino, J.G., Hoek, J.B. (2009). Integration of Energy Metabolism and Control of Apoptosis in Tumor Cells. In: Mitochondria and Cancer. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84835-8_7

Download citation

Publish with us

Policies and ethics

Search

Navigation